A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Tiong, K.T., Rijal, P., Rahikainen, R., Keeble, A.H., Schimanski, L., Hussain, S., Harvey, R., Duyvesteyn, H.M.E., Hayes, J.W.P., Edwards, J.C., McLean, R.K., Martini, V., Pedrera, M., Thakur, N., Conceicao, C., Dietrich, I., Shelton, H., Ludi, A., Wilsden, G., Browning, C., Zagrajek, A.K., Bialy, D., Bhat, S., Stevenson-Leggett, P., Hollinghurst, P., Tully, M., Moffat, K., Chiu, C., Waters, R., Gray, A., Azhar, M., Mioulet, V., Newman, J., Amin, A.S., Burman, A., Crossley, S., Hammond, J.A., Tchilian, E., Charleston, B., Bailey, D., Tuthill, T.J., Graham, S.P., Malinauskas, T., Huo, J., Tree, J.A., Buttigieg, K.R., Owens, R.J., Caroll, M.W., Daniels, R.S., McCauley, J.W., Huang, K.A., Stuart, D.I., Howarth, M., Townsend, A.R.To be published.